{"id":"W2979711603","doi":"10.1186/s40880-019-0405-5","title":"Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Institutes of Health Research","funders":"Renji Hospital; Science and Technology Commission of Shanghai Municipality; Pfizer","keywords":"Sunitinib; Sorafenib; Axitinib; Medicine; Renal cell carcinoma; Oncology; Targeted therapy; Internal medicine; Neoadjuvant therapy; Radiation therapy; Tyrosine-kinase inhibitor; Cancer; Breast cancer; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004353852,0.0004275018,0.001821763,0.001416577,0.0004919263,0.001127796,0.0005411998,0.000799197,0.002485665],"category_scores_gemma":[0.006321681,0.000453359,0.002219585,0.002220678,0.0006571268,0.001215662,0.0005890011,0.0009563823,0.000475558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005489243,"about_ca_system_score_gemma":0.0006903292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004158769,"about_ca_topic_score_gemma":0.0006592532,"domain_scores_codex":[0.9965288,0.0007378797,0.001130576,0.0007111417,0.0006838869,0.0002076544],"domain_scores_gemma":[0.9899772,0.003642259,0.003727595,0.0008156273,0.001154375,0.0006828777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009755284,0.001016961,0.9550548,0.001696794,0.00463244,0.001131872,0.0002284185,0.0002102977,0.0008755711,0.0001450546,0.001291924,0.02396069],"study_design_scores_gemma":[0.002865866,0.02133574,0.9290376,0.0009847741,0.01539742,0.01079318,0.001060537,0.001621216,0.001453263,0.0004207797,0.0147927,0.0002370196],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9586855,0.03690765,0.0009762861,0.0003185136,0.0002275791,0.0004112151,0.001483484,0.00001575154,0.0009741438],"genre_scores_gemma":[0.9882265,0.006641129,0.001020018,0.000637926,0.0007140278,0.0002790712,0.00207737,0.00002362005,0.0003803905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004353852,"threshold_uncertainty_score":0.02302563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08029438110833828,"score_gpt":0.3685204662015316,"score_spread":0.2882260850931934,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}